A clinical formulation indicated for Autoimmune Care. This medicine manages joint inflammation and slows the progression of damage in underlying chronic inflammatory conditions.
Developed to mitigate joint and bowel inflammation to address autoimmune disorders and support long-term remission in patients with arthritis or ulcerative colitis symptoms.
Mechanism of Action
Sulfasalazine is broken down in the gut into two parts: an antibiotic and an anti-inflammatory. It works by reducing the production of inflammatory chemicals in the intestines and joints, calming the immune system's overactive response.
Route of Administration
Oral
Onset Time
4–12 weeks
Duration
12–24 hours
Contraindications
Sulfa allergy, Salicylate allergy, Urinary or intestinal obstruction, Porphyria
Severe Adverse Events
Aplastic anemia, Severe liver toxicity, Severe skin reactions (SJS), Kidney damage, Oligospermia (low sperm count)
Common Side Effects
Yellow-orange urine discoloration, Loss of appetite
Uncommon Side Effects
Nausea, Headache, Stomach upset, Vomiting, Sun sensitivity
Drug Interactions
Digoxin, Folic acid, Warfarin, Iron supplements, Antibiotics
Pregnancy Safety Warnings
Use with caution; folic acid supplementation is required.
Information for Sulfasalazine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
